Loading Events

« All Events

  • This event has passed.

Clinical cases and Michael Feiwel lecture: New treatments for patients with genetic skin diseases

February 18 2021 @ 2:30 PM - 5:00 PM

This RSM webinar will explore clinical cases and present the Michael Feiwel lecture. The lecture will cover recent innovations and new treatments that dermatologists can offer patients in their own clinics.

 

This webinar will cover: 

  • The diagnosis and management of some of the rarer and more unusual dermatology conditions and unusual presentations of common dermatological problems
  • Recent progress in diagnostics and management of dermatological conditions
  • The impact of skin disorders on individuals and the importance of a holistic approach to management
  • New research and treatments in dermatology

Register via the RSM event page.

Details

Date:
February 18 2021
Time:
2:30 PM - 5:00 PM
Event Categories:
, ,
Event Tags:
, , , , ,
Website:
https://www.rsm.ac.uk/events/dermatology/2020-21/dep56/

Venue

Online
United Kingdom
With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
 
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
 
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
 
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.